News

The American Medical Informatics Association argues that when it comes to oversight of clinical decision support systems, the most critical factor in determining the risk classification of different types of software is whether the CDS is mediated by a human being or not.Meryl Bloomrosen, AMIA's vice president for public policy and government relations, has offered those comments in response to the U.S. Food and Drug Administration's (FDA) invitation to participate in a public workshop related to FDA's Draft Guidance on mobile medical applications

Health 2.0 and ONC on Monday launched competitions to develop new health IT apps aimed at easing the transition from hospital to home and reporting medical device adverse events.The competitions, which are now open for submissions, are part of the Investing in Innovation Initiative (i2) and are managed by Health 2.0 through its Health 2.0 Developer Challenge program.